We are live on
!
Find out more
CM
Caption Management Portfolio holdings
AUM
$21.5B
1-Year Est. Return
81.81%
This Fund
S&P 500
This Quarter
Est. Return
+4.28%
1 Year Est. Return
+81.81%
3 Year Est. Return
+226.72%
5 Year Est. Return
+294.21%
10 Year Est. Return
–
AUM
$1.99B
AUM Growth
+$172M
(+9.5%)
Cap. Flow
+$3M
Cap. Flow
% of AUM
0.15%
Top 10 Holdings %
Top 10 Hldgs %
16.27%
Holding
935
New
395
Increased
92
Reduced
99
Closed
294
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$8.42M |
| 2 |
Marathon Petroleum
MPC
|
+$5.47M |
| 3 |
Liberty Global Class C
LBTYK
|
+$5.39M |
| 4 |
O'Reilly Automotive
ORLY
|
+$5.32M |
| 5 |
Crocs
CROX
|
+$5.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$12.6M |
| 2 |
Tapestry
TPR
|
+$12M |
| 3 |
iShares MSCI Saudi Arabia ETF
KSA
|
+$8.32M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$6.96M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
+$6.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 85.48% |
| 2 | Healthcare | 3.75% |
| 3 | Consumer Discretionary | 2.73% |
| 4 | Technology | 1.96% |
| 5 | Energy | 1.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Coherus Oncology
CHRS
$185M
| $1.1M | 0.06% |
+50,000
| New | +$868K |
|
352
Fox Class A
FOXA
$27.7B
| $1.1M | 0.06% |
+30,000
| New | +$1.1M |
|
353
Wayfair
W
$14B
| $1.09M | 0.06% |
+7,500
| New | +$1.13M |
|
|
HOUS
354
CALL
DELISTED
Anywhere Real Estate
HOUS
| $1.09M | 0.05% |
150,000
| – | – |
|
355
PUT
Cinemark Holdings
CNK
$3.99B
| $1.08M | 0.05% |
+30,000
| New | +$1.18M |
|
356
PUT
Cognex
CGNX
$10.3B
| $1.08M | 0.05% |
+22,500
| New | +$1.08M |
|
357
PUT
Community Health Systems
CYH
$416M
| $1.08M | 0.05% |
404,000
-98,500
| -20% | -$311K |
|
358
PUT
TJX Companies
TJX
$137B
| $1.06M | 0.05% |
+20,000
| New | +$1.06M |
|
|
S
359
PUT
DELISTED
Sprint Corporation
S
| $1.05M | 0.05% |
+160,000
| New | +$1.01M |
|
360
Axalta
AXTA
$7.17B
| $1.04M | 0.05% |
+35,000
| New | +$928K |
|
361
CALL
HF Sinclair
DINO
$20.3B
| $1.04M | 0.05% |
+22,500
| New | +$1.01M |
|
362
PUT
TherapeuticsMD
TXMD
$25.6M
| $1.04M | 0.05% |
+8,000
| New | +$1.43M |
|
363
CALL
GoPro
GPRO
$281M
| $1.04M | 0.05% |
190,000
+150,000
| +375% | +$954K |
|
|
NUAN
364
DELISTED
Nuance Communications, Inc.
NUAN
| $1.04M | 0.05% |
+75,075
| New | +$1.11M |
|
365
CALL
DHT Holdings
DHT
$3.73B
| $1.03M | 0.05% |
+175,000
| New | +$953K |
|
|
ODP
366
PUT
DELISTED
ODP
ODP
| $1.03M | 0.05% |
+50,000
| New | +$1.13M |
|
367
Incyte
INCY
$25.6B
| $1.02M | 0.05% |
12,000
| – | – |
|
368
Vistra
VST
$48.3B
| $1.02M | 0.05% |
+45,000
| New | +$1.13M |
|
|
JAX
369
PUT
DELISTED
J. Alexander's Holdings, Inc.
JAX
| $1.01M | 0.05% |
+90,000
| New | +$966K |
|
|
ZGNX
370
DELISTED
Zogenix, Inc.
ZGNX
| $1M | 0.05% |
+21,000
| New | +$846K |
|
371
T-Mobile US
TMUS
$185B
| $1M | 0.05% |
13,500
+2,500
| +23% | +$186K |
|
372
CALL
GSK
GSK
$102B
| $1M | 0.05% |
20,000
| – | – |
|
|
PRAH
373
PUT
DELISTED
PRA Health Sciences, Inc.
PRAH
| $991K | 0.05% |
10,000
-20,000
| -67% | -$1.91M |
|
374
International Paper
IP
$18.4B
| $975K | 0.05% |
+23,760
| New | +$1.01M |
|
|
375
Community Health Systems
CYH
$416M
| $972K | 0.05% |
364,200
+64,200
| +21% | +$203K |
|
Similar funds
AWM
LCIP
BPA
SA
AA
RAM
FCM
BG
Caption Management's Q2 2019 Portfolio in Review
As of Q2 2019, Caption Management held 935 positions worth $1.99B, up 9.5% from $1.81B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Caption Management's Q2 2019 filing shows 395 new, 92 increased, 99 reduced and 294 closed positions. Its largest new stake was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M. The largest sale was Bristol-Myers Squibb, an estimated $12.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 85% of assets, up from 85% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Caption Management's largest Q2 2019 buy was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.
- Caption Management added most to Crocs in Q2 2019, an estimated $5.07M increase.
- Caption Management's biggest Q2 2019 reduction was Bristol-Myers Squibb, cutting an estimated $12.6M.
- Caption Management fully exited iShares MSCI Saudi Arabia ETF in Q2 2019, selling an estimated $8.32M.
- Caption Management's ten largest holdings make up 16% of its $1.99B portfolio in Q2 2019.
- Caption Management opened 395 new positions and closed 294 in Q2 2019.
- Caption Management's portfolio value rose 9.5% quarter-over-quarter to $1.99B.
Based on Caption Management's 13F filing for Q2 2019, filed 13 Aug 2019.